Profund Advisors LLC Has $253,000 Holdings in Balchem Co. (NASDAQ:BCPC)

Profund Advisors LLC lessened its holdings in Balchem Co. (NASDAQ:BCPC) by 8.6% in the 2nd quarter, Holdings Channel reports. The firm owned 1,644 shares of the basic materials company’s stock after selling 155 shares during the quarter. Profund Advisors LLC’s holdings in Balchem were worth $253,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of BCPC. Bessemer Group Inc. lifted its position in Balchem by 568.9% during the 1st quarter. Bessemer Group Inc. now owns 301 shares of the basic materials company’s stock worth $47,000 after acquiring an additional 256 shares during the last quarter. YHB Investment Advisors Inc. acquired a new position in Balchem during the 1st quarter worth $69,000. GAMMA Investing LLC lifted its position in Balchem by 18.0% during the 1st quarter. GAMMA Investing LLC now owns 473 shares of the basic materials company’s stock worth $73,000 after acquiring an additional 72 shares during the last quarter. TD Asset Management Inc acquired a new position in Balchem during the 2nd quarter worth $200,000. Finally, Heritage Family Offices LLP acquired a new position in Balchem during the 2nd quarter worth $206,000. Institutional investors and hedge funds own 87.91% of the company’s stock.

Insider Activity

In other news, SVP Gunsteren Job Leonard Van sold 7,750 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $180.05, for a total transaction of $1,395,387.50. Following the completion of the transaction, the senior vice president now owns 8,540 shares of the company’s stock, valued at $1,537,627. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.25% of the stock is owned by company insiders.

Balchem Stock Down 0.0 %

Shares of BCPC opened at $175.13 on Friday. The company has a 50-day simple moving average of $171.68 and a 200-day simple moving average of $159.94. The firm has a market capitalization of $5.68 billion, a P/E ratio of 49.47, a P/E/G ratio of 5.54 and a beta of 0.65. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.79 and a current ratio of 2.83. Balchem Co. has a 52 week low of $110.74 and a 52 week high of $186.03.

Balchem (NASDAQ:BCPC) last announced its quarterly earnings data on Friday, July 26th. The basic materials company reported $0.98 EPS for the quarter, beating analysts’ consensus estimates of $0.95 by $0.03. The business had revenue of $234.08 million during the quarter, compared to analyst estimates of $241.26 million. Balchem had a net margin of 12.52% and a return on equity of 10.94%. On average, equities research analysts expect that Balchem Co. will post 3.96 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on BCPC shares. StockNews.com lowered shares of Balchem from a “buy” rating to a “hold” rating in a research report on Monday, July 29th. HC Wainwright boosted their target price on shares of Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a research report on Wednesday, July 31st.

Balchem Company Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.